Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Lupus Science & Medicine|July 8, 2024
Antiplatelet effects of hydroxychloroquine in patients with systemic lupus erythematosus evaluated by the total thrombus-formation analysis system (T-TAS)Daisuke Hiraoka, Jun Ishizaki, Jun Yamanouchi, et al.
Transplantation and Cellular Therapy|October 7, 2025
Impact of Oral Eicosapentaenoic Acid on Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Onset Prevention: Single-Center Retrospective AnalysisYukihiro Miyazaki, Hiroshi Narumi, Taichi Azuma, et al.
Diabetes|October 17, 2009
Idd9.1 locus controls the suppressive activity of FoxP3+CD4+CD25+ regulatory T-cellsJun Yamanouchi, Maria-Carmen Puertas, Joan Verdaguer, et al.
The Journal of Clinical Investigation|March 4, 2020
Ubiquitous antigen-specific T regulatory type 1 cells variably suppress hepatic and extrahepatic autoimmunityChannakeshava Sokke Umeshappa, Jacques Mbongue, Santiswarup Singha, et al.
Molecular Biology of the Cell|May 30, 2008
Differences in regulation of Drosophila and vertebrate integrin affinity by talinTeresa L Helsten, Thomas A Bunch, Hisashi Kato, et al.
Journal for Immunotherapy of Cancer|June 24, 2025
Bystander CAR-CD8+ T cells in a CAR-T cell product can expand and enhance the antitumor effects of a bispecific antibodyJunichi Kato, Tatsuya Konishi, Takatsugu Honda, et al.
Nature Communications|October 31, 2019
Increased yields and biological potency of knob-into-hole-based soluble MHC class II moleculesPau Serra, Nahir Garabatos, Santiswarup Singha, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|July 2, 2013
Empirical voriconazole therapy for febrile neutropenic patients with hematological disorders: a prospective multicenter trial in JapanHideo Koh, Masayuki Hino, Kensuke Ohta, et al.
International Journal of Hematology|May 20, 2025
A phase 3 study of the efficacy and safety of avatrombopag in Japanese adults with chronic immune thrombocytopeniaHiroki Yamaguchi, Masaki Iino, Shugo Kowata, et al.
Nature Communications|June 7, 2022
Re-programming mouse liver-resident invariant natural killer T cells for suppressing hepatic and diabetogenic autoimmunityChannakeshava Sokke Umeshappa, Patricia Solé, Jun Yamanouchi, et al.
Pageof 9